Flow cytometric analysis of Human CD11a expression on human peripheral blood Leukocytes. Human peripheral blood Leukocytes were stained with either PE-Cy7 Mouse IgG1, κ Isotype Control (Black line histogram) or SDT PE-Cy7 Mouse Anti-Human CD11a antibody (Red line histogram) at 1.25 μl/test treated with True-Stain Monocyte Blocker™, cells without incubation with primary antibody and secondary antibody (Blue line histogram) was used as unlabelled control. Flow cytometry and data analysis were performed using BD FACSymphony™ A1 and FlowJo™ software.
PE-Cy7 Mouse Anti-Human CD11a Antibody (S-R402)
PE-Cy7 Mouse Anti-Human CD11a Antibody (S-R402)
Price:
Regular price
$196.00 SGD
Regular price
Sale price
$196.00 SGD
Unit price
per
For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details
Product Details
Product Details
Product Specification
| Host | Mouse |
| Antigen | CD11a |
| Synonyms | Integrin alpha-L; CD11 antigen-like family member A; Leukocyte adhesion glycoprotein LFA-1 alpha chain (LFA-1A); Leukocyte function-associated molecule 1 alpha chain; CD11A; ITGAL |
| Location | Cell membrane |
| Accession | P20701 |
| Clone Number | S-R402 |
| Antibody Type | Mouse mAb |
| Isotype | IgG1,k |
| Application | FCM |
| Reactivity | Hu |
| Positive Sample | Human peripheral blood Leukocytes |
| Purification | Protein G |
| Concentration | 0.2 mg/ml |
| Conjugation | PE-Cy7 |
| Physical Appearance | Liquid |
| Storage Buffer | PBS, 1% BSA, 0.3% Proclin 300 |
| Stability & Storage | 12 months from date of receipt / reconstitution, 2 to 8 °C as supplied |
Dilution
| application | dilution | species |
| FCM | 1.25μl per million cells in 100μl volume | Hu |
Background
CD11a, also known as integrin alpha L, is a protein encoded by the ITGAL gene in humans and is a critical component of the leukocyte function-associated antigen-1 (LFA-1) complex, which is essential for immune cell adhesion and signaling. It pairs with CD18 to form LFA-1, a heterodimeric transmembrane protein that mediates interactions between leukocytes and other cells, such as T cells and antigen-presenting cells. This interaction is crucial for leukocyte migration to sites of inflammation and the formation of immunological synapses. CD11a is expressed on all leukocytes and plays a key role in immune surveillance and inflammatory responses. It is also a target for therapeutic agents like efalizumab, which was used to treat psoriasis by inhibiting the interaction between LFA-1 and its ligands, such as ICAM-1.
Picture
Picture
FC
